Record mula sa primary source
Decision-gradePag-apruba ng FDA
Amneal Pharmaceuticals, Inc. Class A · Pinahintulutan ng FDA ang Boncresa (denosumab-mobz)
FDA's Purple Book lists BLA 761456 (Boncresa, denosumab-mobz; Amneal Pharmaceuticals LLC, CDER) as licensed on 2025-12-19.
Mahahalagang fact
- Na-file
- Dis 19, 2025, 12:00 AM
- Kaganapan
- Pag-apruba ng FDA
- Direksyon
- Positibo
- Kumpiyansa
- May source
AMRXAmneal